Back to Search
ROBERTO ALVAREZ, M.D.
M.D.
Family Medicine Physician
NPI: 1427065283IndividualAccepts Medicare
Specialties, Licenses & Credentials
Legal Medicine
Legal Medicine
Code: 173000000X
H6009(TX)
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
H6009(TX)
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Class of 1988
Research & Publications (20)
The biology of chronic myelogenous leukemia: implications for imatinib therapy.
PMID 17292736·Semin Hematol·2007
6-review
Biology of platelet-derived growth factor and its involvement in disease.
PMID 16970222·Mayo Clin Proc·2006
6-review
The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors.
PMID 16986126·Cancer·2006
6-review
Superovulatory response of zebu cows treated with pFSH in a single subcutaneous injection followed by an additional intramuscular sub-dose 48 h later.
PMID 19144011·Reprod Domest Anim·2010
7-preclinical
Isocombretastatins A: 1,1-diarylethenes as potent inhibitors of tubulin polymerization and cytotoxic compounds.
PMID 19647439·Bioorg Med Chem·2009
8-other
Effect of TRA-8 anti-death receptor 5 antibody in combination with chemotherapy in an ex vivo human ovarian cancer model.
PMID 19574765·Int J Gynecol Cancer·2009
8-other
Advancements in adenoviral based virotherapy for ovarian cancer.
PMID 19422865·Adv Drug Deliv Rev·2009
6-review
Lower risk of cervical intraepithelial neoplasia in women with high plasma folate and sufficient vitamin B12 in the post-folic acid fortification era.
PMID 19542191·Cancer Prev Res (Phila)·2009
8-other
Ozone oxidative preconditioning reduces nitrite levels in blood serum in LPS: induced endotoxic shock in mice.
PMID 19533019·Inflamm Res·2009
7-preclinical
Genetic transformation of cork oak (Quercus suber L.) for herbicide resistance.
PMID 19543858·Biotechnol Lett·2009
8-other
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.
PMID 19509153·Clin Cancer Res·2009
7-preclinical
RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy.
PMID 19506055·Antimicrob Agents Chemother·2009
7-preclinical
Retinoic acid and Wnt/beta-catenin have complementary roles in anterior/posterior patterning embryos of the basal chordate amphioxus.
PMID 19497318·Dev Biol·2009
7-preclinical
Phase II trial of ixabepilone as second-line treatment in advanced endometrial cancer: gynecologic oncology group trial 129-P.
PMID 19451430·J Clin Oncol·2009
3-trial
Retinoid receptor subtype-selective modulators through synthetic modifications of RARgamma agonists.
PMID 19482478·Bioorg Med Chem·2009
8-other
Prognostic and predictive markers of benefit from adjuvant chemotherapy in early-stage non-small cell lung cancer.
PMID 19433989·J Thorac Oncol·2009
6-review
Singlet oxygen quenching and radical scavenging capacities of structurally-related flavonoids present in Zuccagnia punctata Cav.
PMID 19431060·Free Radic Res·2009
8-other
C3 halogen and c8'' substituents on stilbene arotinoids modulate retinoic Acid receptor subtype function.
PMID 19670208·ChemMedChem·2009
8-other
Pivotal role of dihydrofolate reductase knockdown in the anticancer activity of 2-hydroxyoleic acid.
PMID 19666584·Proc Natl Acad Sci U S A·2009
8-other
Human immunodeficiency virus testing uptake and risk behaviours in Spain.
PMID 19525249·J Epidemiol Community Health·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9511 HUFFMEISTER RD STE 100
HOUSTON, TX 77095 - Phone
- (713) 461-2915
Quick Facts
- NPI
- 1427065283
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile